glp-1 drugs for inflammation medication side effects diabetes and weight loss Beyond Weight Loss: How GLP-1

Renal Acute Kidney Injury Acute kidney injury is an uncommon but recognized complication of GLP-1 receptor agonists

Furthermore, these medications contribute to improved metabolic health and may lower the risk of cardiovascular diseases

Thus, a shift toward increased clinical utility is influencing the industry competition in favor of GLP-1 receptor agonists and attracting investments into research and development projects aimed at improving therapeutic options

Both public and private payers use cost containment policies to control the amount and mix of drugs included under the prescription drug benefit, which may be administered by a pharmacy benefit manager, or PBM

Safety Monitoring: Who Needs Enhanced Lab Surveillance Patients with pre-existing kidney disease, liver cirrhosis, thyroid nodules, or personal/family history of medullary thyroid cancer require more frequent biomarker checks and may not be candidates for GLP-1 therapy

Thirty-four reported adverse effects, including hypersensitivity, injection-site reactions, pruritus, urticaria, angioedema, and immune-mediated conditions like bullous pemphigoid